Alisertib (MLN8237) an investigational agent suppresses...

Leukemia Research 2013 / 4 Vol. 37; Iss. 4

Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment

Qi, Wenqing, Spier, Catherine, Liu, Xiaobing, Agarwal, Amit, Cooke, Laurence S., Persky, Daniel O., Chen, Deyu, Miller, Thomas P., Mahadevan, Daruka
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
37
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/j.leukres.2012.10.017
Date:
April, 2013
File:
PDF, 869 KB
english, 2013
Conversion to is in progress
Conversion to is failed